CORRECTION article

Front. Microbiol., 12 February 2019

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 10 - 2019 | https://doi.org/10.3389/fmicb.2019.00196

Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii

  • 1. Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China

  • 2. Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China

  • 3. Department of Clinical Laboratory, Shanghai Public Health Clinical Center, Shanghai, China

  • 4. Department of Clinical Laboratory, Shanghai Fourth People's Hospital affiliated to Tongji University School of Medicine, Shanghai, China

Article metrics

View details

5

Citations

2k

Views

1,2k

Downloads

There is an error in the Funding statement. The correct name for the Funder is “Shanghai Municipal Commission of Health and Family Planning.”

Additionally, in the published article, there were errors in affiliations 1 and 4. Instead of “Department of Clinical Laboratory, Pudong Hospital Affiliated to Fudan University, Shanghai, China,” it should be “Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China,” and in affiliation 4, instead of “Department of Clinical Laboratory, The Fourth People's Hospital of Shanghai, Shanghai, China,” it should be “Department of Clinical Laboratory, Shanghai Fourth People's Hospital affiliated to Tongji University School of Medicine, Shanghai, China.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

multidrug resistance Acinetobacter baumannii, endolysin, ESKAPE, sepsis, phage therapy, mice model

Citation

Wu M, Hu K, Xie Y, Liu Y, Mu D, Guo H, Zhang Z, Zhang Y, Chang D and Shi Y (2019) Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii. Front. Microbiol. 10:196. doi: 10.3389/fmicb.2019.00196

Received

13 January 2019

Accepted

23 January 2019

Published

12 February 2019

Approved by

Frontiers in Microbiology Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2019

Updates

Copyright

*Correspondence: Yi Shi Dong Chang

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics